Nigou Jérôme, Vasselon Thierry, Ray Aurélie, Constant Patricia, Gilleron Martine, Besra Gurdyal S, Sutcliffe Iain, Tiraby Gérard, Puzo Germain
Institut de Pharmacologie et de Biologie Structurale, Centre National de la Recherche Scientifique Unité Mixte de Recherche 5089, Department of Molecular Mechanisms of Mycobacterial Infections, Toulouse, France.
J Immunol. 2008 May 15;180(10):6696-702. doi: 10.4049/jimmunol.180.10.6696.
TLR2 is a pattern-recognition receptor that is activated by a large variety of conserved microbial components, including lipoproteins, lipoteichoic acids, and peptidoglycan. Lipoglycans are TLR2 agonists found in some genera of the phylogenetic order Actinomycetales, including Mycobacterium. They are built from a mannosyl-phosphatidyl-myo-inositol anchor attached to a (alpha1-->6)-linked d-mannopyranosyl chain whose units can be substituted by d-mannopyranosyl and/or d-arabinofuranosyl units. At this time, little is known about the molecular bases underlying their ability to induce signaling via this receptor. We have recently shown that the anchor must be at least triacylated, including a diacylglyceryl moiety, whereas the contribution of the glycosidic moiety is not yet clearly defined. We show herein that lipoglycan activity is directly determined by mannan chain length. Indeed, activity increases with the number of units constituting the (alpha1-->6)-mannopyranosyl backbone but is also critically dependent on the substitution type of the 2-hydroxyl of these units. We thus provide evidence for the definition of a new pattern that includes the nonlipidic moiety of the molecules, most probably as a result of the (alpha1-->6)-mannopyranosyl backbone being a highly conserved structural feature among lipoglycans. Moreover, we demonstrate that lipoglycans can bind cell surface-expressed TLR2 and that their ability to induce signaling might be, at least in part, dictated by their avidity for the receptor. Finally, our data suggest that lipoglycans and lipoproteins have a common binding site. The present results are thus discussed in the light of the recently published crystal structure of a TLR1-TLR2-lipopeptide complex.
Toll样受体2(TLR2)是一种模式识别受体,可被多种保守的微生物成分激活,包括脂蛋白、脂磷壁酸和肽聚糖。脂多糖是在放线菌目某些属中发现的TLR2激动剂,包括分枝杆菌属。它们由连接到(α1→6)连接的d-甘露吡喃糖基链上的甘露糖基磷脂酰肌醇锚构建而成,其单元可被d-甘露吡喃糖基和/或d-阿拉伯呋喃糖基单元取代。目前,关于它们通过该受体诱导信号传导能力的分子基础知之甚少。我们最近表明,锚定部分必须至少三酰化,包括二酰甘油部分,而糖苷部分的贡献尚未明确界定。我们在此表明,脂多糖活性直接由甘露聚糖链长度决定。事实上,活性随着构成(α1→6)-甘露吡喃糖基主链的单元数量增加而增加,但也关键取决于这些单元2-羟基的取代类型。因此,我们提供了一种新模式定义的证据,该模式包括分子的非脂质部分,很可能是由于(α1→6)-甘露吡喃糖基主链是脂多糖中高度保守的结构特征。此外,我们证明脂多糖可以结合细胞表面表达的TLR2,并且它们诱导信号传导的能力可能至少部分地由它们对受体的亲和力决定。最后,我们的数据表明脂多糖和脂蛋白有一个共同的结合位点。因此,根据最近发表的TLR1-TLR2-脂肽复合物的晶体结构对目前的结果进行了讨论。